Talzenna .25 mg/1 (Talazoparib CAPSULE) .25 mg/1

Talzenna .25 mg/1 is a medication used to treat certain types of cancer. This oral capsule, manufactured by Pfizer, contains the active ingredient talazoparib. Learn more about its uses and effects.

Strength

.25 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0069-0296-30) / 30 CAPSULE in 1 BOTTLE

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna .25 mg/1 is primarily used in the treatment of specific cancers. It works by targeting certain proteins involved in cancer cell growth. Talazoparib, the active ingredient, is often prescribed for conditions where other treatments may not be effective. Patients and healthcare providers may explore its use for various types of cancer, including those that are hereditary.

Side Effects

Common effects of Talzenna .25 mg/1 may include fatigue, nausea, and anemia. Some users might experience changes in taste or appetite. It's important to discuss any persistent or severe effects with a healthcare professional. The medication's impact can vary depending on individual health factors.

Precautions & Warnings

Talzenna .25 mg/1 should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication. Proper storage and disposal of the capsules are also important to ensure safety.

Avoid Interactions

Talzenna .25 mg/1 may interact with other medications, including those that affect liver enzymes. Alcohol and certain supplements might also influence its effectiveness. It's crucial to discuss all current medications and supplements with a healthcare provider to avoid potential interactions. Always consult a professional before making any changes to your medication regimen.

Frequently Asked Questions

Talzenna .25 mg/1 is used in the treatment of specific types of cancer, often where other treatments may not be effective.

Talzenna .25 mg/1 is taken orally in capsule form. Follow the dosage and administration instructions provided by your healthcare professional.

Common effects may include fatigue, nausea, and anemia. Always discuss any persistent or severe effects with your healthcare provider.

Talzenna .25 mg/1 may interact with other medications. Consult your healthcare provider before combining it with other treatments.

Follow the prescribed dosage and administration instructions. Inform your healthcare provider of any medical conditions or allergies before starting the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.